ELASTY® D Plus with Lidocaine – Cross-Linked HA Dermal Filler | 1 × 1ml

Product Overview

ELASTY® D Plus with Lidocaine is a professional cross-linked Hyaluronic Acid (HA) dermal filler developed for medium to deep wrinkle correction, facial fold treatment, soft tissue augmentation and natural-looking facial volume restoration.

Manufactured in South Korea, ELASTY® D Plus contains 24mg/ml cross-linked Hyaluronic Acid and 0.3% Lidocaine, combining a cohesive, medium-viscosity HA gel with a local anaesthetic designed to improve patient comfort during treatment.

ELASTY® D Plus is manufactured using PNET® – Preserved Natural Entanglement Technology, the brand's proprietary HA gel technology designed to preserve the natural entanglement characteristics of Hyaluronic Acid chains while creating a stable, elastic and cohesive injectable matrix.

Positioned as a medium-viscosity, tissue-supportive formulation within the ELASTY® dermal filler range, D Plus is designed to provide greater filling capacity and support than softer HA formulations while maintaining balanced elasticity, firmness and natural-looking tissue integration.

Its formulation makes it particularly relevant to practitioner-led treatments where the objective is to correct more pronounced facial wrinkles and folds, restore selected areas of volume loss or provide controlled soft tissue augmentation.

Potential professional treatment objectives include:

• Medium to deep wrinkle correction

• Pronounced facial fold correction

• Nasolabial fold improvement

• Marionette line correction

• Lip volume augmentation

• Lip contour enhancement

• Soft tissue augmentation

• Moderate facial volume restoration

• Lower-face rejuvenation

• Facial contour refinement

The cross-linked HA gel provides immediate physical correction following appropriate placement, while the hydrophilic properties of Hyaluronic Acid contribute to moisture retention within the treated tissue.

ELASTY® D Plus also contains 0.3% Lidocaine, incorporated to help reduce injection-related discomfort.

Unlike non-cross-linked skin boosters or regenerative Polynucleotide products, ELASTY® D Plus is primarily a dermal filler designed to provide physical wrinkle correction, soft tissue support and volume restoration.

ELASTY® D Plus is intended strictly for use by appropriately qualified medical or aesthetic professionals trained in dermal filler procedures.

Pack Contents

Each pack contains:

• 1 × 1ml pre-filled syringe of ELASTY® D Plus

• Cross-Linked Hyaluronic Acid: 24mg/ml

• Lidocaine: 0.3%

• Sterile injection needle(s), as supplied with the individual product presentation

• Sterile, sealed professional-use packaging

Volume per Syringe: 1ml

Total Product Volume: 1ml

Always check the individual product packaging, manufacturer labelling, needle specifications and current Instructions for Use before administration.

Product Composition

Cross-Linked Hyaluronic Acid – 24mg/ml

ELASTY® D Plus contains 24mg/ml highly purified cross-linked Hyaluronic Acid within a professional injectable dermal filler gel.

Hyaluronic Acid is naturally present within human tissues and plays an important role in hydration and extracellular matrix function.

Cross-linking improves the stability and persistence of the HA gel compared with non-cross-linked Hyaluronic Acid formulations, allowing the product to provide physical correction and support within appropriately selected tissues.

Within ELASTY® D Plus, the cross-linked HA is designed to provide:

• Medium to deep wrinkle correction

• Facial fold correction

• Soft tissue augmentation

• Moderate volume restoration

• Facial contour refinement

• Tissue support

• Natural-looking aesthetic correction

The medium-viscosity formulation is designed to provide greater filling capacity than softer HA fillers while retaining appropriate flexibility and cohesion.

Lidocaine – 0.3%

ELASTY® D Plus contains 0.3% Lidocaine.

Lidocaine is a local anaesthetic incorporated into the formulation to help reduce injection-related discomfort and improve patient comfort during professional administration.

Patients should be assessed for relevant hypersensitivities, allergies and contraindications before treatment.

Highly Purified Hyaluronic Acid

The ELASTY® range is developed using purified Hyaluronic Acid within professional injectable gel formulations designed for aesthetic correction and soft tissue augmentation.

Medium-Viscosity HA Gel Matrix

ELASTY® D Plus features a medium-viscosity HA gel designed to provide a balance of:

• Filling capacity

• Firmness

• Elasticity

• Cohesion

• Tissue support

• Mouldability

• Natural-looking integration

These characteristics make it relevant to facial treatments requiring greater correction than would typically be achieved with a softer filler.

Cohesive Cross-Linked HA Structure

The cohesive gel matrix is designed to support controlled product delivery and maintain the intended correction following appropriate placement.

PNET® – Preserved Natural Entanglement Technology

ELASTY® dermal fillers are manufactured using PNET® – Preserved Natural Entanglement Technology, the brand's proprietary Hyaluronic Acid filler technology.

PNET® is designed to create a stable and cohesive HA gel matrix while preserving the natural entanglement characteristics of Hyaluronic Acid chains.

Preserved HA Chain Entanglement

The manufacturing process is designed around preserving the natural entanglement of HA chains within the gel matrix.

High Elasticity

Elasticity supports the gel's ability to respond to normal tissue movement while maintaining the intended aesthetic correction.

Strong Cohesion

Cohesion helps maintain gel integrity and supports controlled placement within appropriately selected tissues.

Firm Tissue Support

The gel structure is designed to provide filling capacity and support in areas affected by medium to deep wrinkles, pronounced folds and selected volume deficiencies.

Resistance to Premature Biodegradation

The cross-linked HA matrix is designed to improve gel stability and persistence compared with non-cross-linked HA formulations.

Controlled Product Delivery

The cohesive gel characteristics are designed to support smooth and controlled extrusion during professional administration.

Natural-Looking Tissue Integration

The balance of elasticity, firmness and cohesion is intended to support smooth integration and refined aesthetic correction.

Together, these characteristics position ELASTY® D Plus as a versatile, tissue-supportive filler for deeper wrinkle correction and moderate volume restoration.

Medium-Viscosity HA Formulation

ELASTY® D Plus is positioned as a medium-viscosity formulation within the ELASTY® range.

Its gel characteristics are designed to provide greater support than softer HA fillers while maintaining sufficient flexibility for natural-looking facial correction.

This balance may be particularly relevant when treating:

• Medium to deep facial wrinkles

• Pronounced facial folds

• Selected areas of volume loss

• Lips where clinically appropriate

• Lower-face contours

• Selected soft tissue deficiencies

The appropriate product should always be selected according to its characteristics, manufacturer-authorised indications and individual patient anatomy.

Medium to Deep Wrinkle Correction

ELASTY® D Plus is developed for professional treatments where greater wrinkle-correcting capacity is required than would typically be provided by a softer filler.

Potential treatment objectives include:

• Softening medium to deep facial wrinkles

• Improving pronounced facial folds

• Supporting selected areas affected by volume loss

• Restoring smoother facial transitions

• Improving lower-face contours

• Providing natural-looking rejuvenation

The degree of correction should always be appropriate to the patient's anatomy, tissue characteristics and desired aesthetic outcome.

Nasolabial Fold Correction

Nasolabial folds can become more pronounced as a result of age-related changes in facial volume, skin elasticity and supporting structures.

ELASTY® D Plus may be considered for appropriately selected nasolabial fold treatments where additional filling capacity and tissue support are required.

Potential objectives include:

• Softening the appearance of pronounced folds

• Improving facial transitions

• Supporting selected areas of volume deficiency

• Restoring natural-looking facial contours

Treatment planning should consider the underlying cause of the fold rather than focusing solely on the visible crease.

Marionette Lines & Lower-Face Rejuvenation

ELASTY® D Plus may also be considered for selected lower-face treatments.

Potential objectives include:

• Improving the appearance of appropriate marionette lines

• Supporting selected areas of soft tissue volume loss

• Refining lower-face contours

• Improving facial balance

• Restoring smoother transitions around the lower face

Treatment should be individually planned according to facial anatomy, tissue characteristics and the degree of correction required.

Lip Volume & Contour Enhancement

The supplied product information identifies lip augmentation and contour enhancement as potential applications for ELASTY® D Plus.

Where supported by the manufacturer's current Instructions for Use and appropriate following professional assessment, potential objectives may include:

• Lip volume augmentation

• Lip contour refinement

• Improved lip definition

• Correction of selected asymmetry

• Restoration of age-related lip volume loss

• Natural-looking lip enhancement

Lip treatments require careful consideration of tissue characteristics, existing proportions, vascular anatomy and patient expectations.

Product selection should reflect the desired degree of volume and support rather than HA concentration alone.

Soft Tissue Augmentation

ELASTY® D Plus is designed to provide physical support and moderate volume restoration in appropriately selected tissues.

Potential objectives may include:

• Restoring selected areas of facial volume

• Improving soft tissue contours

• Supporting age-related facial changes

• Correcting appropriate volume deficiencies

• Improving facial symmetry

• Providing balanced aesthetic enhancement

The aim should be proportionate restoration that maintains natural facial harmony.

Key Benefits

• Professional cross-linked HA dermal filler

• 1 × 1ml pre-filled syringe

• Contains 24mg/ml Hyaluronic Acid

• Contains 0.3% Lidocaine

• Manufactured using PNET® technology

• Medium-viscosity HA gel formulation

• Designed for medium to deep wrinkle correction

• Supports correction of pronounced facial folds

• Provides greater filling capacity than softer HA formulations

• Supports natural-looking soft tissue augmentation

• Suitable for selected lip augmentation protocols

• Supports moderate facial volume restoration

• Helps improve selected nasolabial folds

• Supports lower-face rejuvenation

• Supports facial contour refinement

• Provides immediate physical correction

• Balanced elasticity, firmness and cohesion

• Designed for controlled product delivery

• Supports natural-looking tissue integration

• Cross-linked HA matrix supports gel stability

• Designed for improved persistence compared with non-cross-linked HA

• Lidocaine-containing formulation supports treatment comfort

• Suitable for practitioner-led facial rejuvenation

• Intended strictly for appropriately qualified professional use

Common Treatment Areas

The supplied product information identifies potential treatment areas including:

• Nasolabial folds

• Marionette lines

• Medium to deep facial wrinkles

• Pronounced facial folds

• Lips

• Lip volume augmentation

• Lip contour enhancement

• Perioral region where clinically appropriate

• Lower-face rejuvenation

• Selected cheek and mid-face correction

• Selected areas of facial volume loss

• Soft tissue augmentation

• Facial contour refinement

• Selected forehead wrinkles where clinically appropriate

Treatment-area recommendations may vary according to the manufacturer's current Instructions for Use and the individual product supplied.

Not every area will be appropriate for every patient.

Certain facial regions, including the forehead, carry elevated vascular risks and require particular anatomical knowledge and professional competence.

Treatment suitability should therefore always be determined according to:

• Manufacturer-authorised indications

• Facial anatomy

• Vascular anatomy

• Tissue characteristics

• Wrinkle or fold depth

• Degree of volume loss

• Previous aesthetic treatments

• Practitioner competence

• Individual treatment objectives

Always follow the manufacturer's current Instructions for Use regarding approved indications, treatment depth, product placement, technique and volume.

ELASTY® F Plus vs D Plus vs G Plus

The ELASTY® Plus range provides different gel characteristics for different levels of aesthetic correction.

ELASTY® F Plus – Refined Correction

Positioned primarily for:

• Fine to moderate wrinkles

• Softer tissue correction

• Subtle volume restoration

• Selected facial folds

• Natural-looking rejuvenation

• Moderate soft tissue support

Primary focus: Refined wrinkle correction and subtle augmentation.

ELASTY® D Plus – Balanced Filling & Support

Positioned primarily for:

• Medium to deep wrinkles

• Pronounced facial folds

• Moderate volume restoration

• Lip augmentation

• Soft tissue augmentation

• Lower-face rejuvenation

Primary focus: Balanced filling capacity, tissue support and natural-looking volume restoration.

ELASTY® G Plus – Structural Volume & Projection

Positioned primarily for:

• Deeper facial correction

• Greater volume restoration

• Structural tissue support

• Facial projection

• Advanced contour enhancement

• Selected structural augmentation treatments

Primary focus: Greater structural support, projection and facial contouring.

The progression can therefore be considered:

F Plus → Finer Correction

D Plus → Deeper Wrinkle Correction & Balanced Volume

G Plus → Greater Structural Support & Projection

All three formulations are described in the supplied product information as containing:

• 24mg/ml Hyaluronic Acid

• 0.3% Lidocaine

However, their intended gel characteristics and treatment objectives differ.

Practitioners should select the appropriate product according to manufacturer-authorised indications, rheological properties, patient anatomy and individual treatment objectives.

ELASTY® D Plus vs Standard ELASTY® D

Standard ELASTY® D and ELASTY® D Plus should be treated as distinct product variants.

Standard ELASTY® D

Based on the previously supplied product information:

• Cross-linked HA dermal filler

• 24mg/ml Hyaluronic Acid

• Medium-density formulation

• Positioned for moderate to deep wrinkles

• Supports moderate facial volume restoration

• Supplied as 2 × 1ml

ELASTY® D Plus

• Cross-linked HA dermal filler

• 24mg/ml Hyaluronic Acid

• 0.3% Lidocaine

• Medium-viscosity formulation

• Positioned for medium to deep wrinkle correction

• Supports soft tissue augmentation

• Supplied as 1 × 1ml

The Lidocaine-containing formulation is designed to improve patient comfort during administration.

Specifications should not be transferred between standard and Plus variants without checking the exact product packaging.

ELASTY® D Plus vs Skin Boosters

ELASTY® D Plus should not be confused with a non-cross-linked HA skin booster.

HA Skin Boosters

These products primarily focus on:

• Hydration

• Moisture retention

• Skin texture

• Elasticity

• General skin-quality improvement

ELASTY® D Plus

As a cross-linked HA dermal filler, D Plus is designed primarily for:

• Physical wrinkle correction

• Facial fold treatment

• Soft tissue augmentation

• Moderate volume restoration

• Tissue support

• Facial contour refinement

Its primary purpose is therefore physical aesthetic correction rather than general skin hydration or regenerative biostimulation.

Recommended Treatment Approach

ELASTY® D Plus should only be administered following comprehensive professional assessment.

The supplied product information describes the following general approach:

• Initial Treatment: Single treatment session

• Product Volume: Individually determined

• Treatment Technique: Selected according to treatment area, practitioner training and manufacturer guidance

• Treatment Depth: Determined according to anatomy, tissue characteristics and current Instructions for Use

• Review: Commonly approximately 2–4 weeks following treatment

• Additional Correction: May be considered following clinical reassessment where appropriate

• Maintenance: Individually determined according to product persistence and treatment goals

These intervals should not be considered a universal treatment protocol.

The manufacturer's current Instructions for Use should always take precedence.

Professional Treatment Considerations

ELASTY® D Plus should only be administered by appropriately qualified and trained medical or aesthetic professionals with suitable competence in HA dermal filler procedures.

Treatment planning should include:

• Comprehensive patient consultation

• Full medical history

• Detailed facial assessment

• Assessment of facial proportions

• Assessment of tissue characteristics

• Evaluation of vascular anatomy

• Review of previous aesthetic procedures

• Assessment of contraindications

• Consideration of Lidocaine-related contraindications

• Discussion of realistic treatment expectations

• Explanation of potential adverse effects and complications

• Appropriate documented informed consent

Treatment depth, product volume, administration technique and distribution should always be determined according to individual anatomy, treatment objectives and the manufacturer's current Instructions for Use.

Results & Treatment Outcomes

ELASTY® D Plus provides immediate physical correction, filling and tissue support following appropriate professional placement.

Depending upon the treatment area and objectives, potential outcomes may include:

• Smoother-looking medium to deep wrinkles

• Improvement in pronounced facial folds

• Restored facial volume

• Improved lip volume where appropriate

• Enhanced lip definition

• Improved soft tissue contours

• Improved facial balance

• Natural-looking facial rejuvenation

Initial treatment-related swelling may temporarily influence the appearance of the treated area.

The final aesthetic result becomes clearer as swelling resolves and the filler integrates within the surrounding tissues.

Results & Longevity

The supplied professional product information describes results as commonly lasting approximately:

8–12 months

This should be considered an approximate range rather than a guaranteed duration.

Individual longevity may vary according to:

• Treatment area

• Product volume

• Treatment technique

• Treatment depth

• Patient metabolism

• Facial movement

• Patient age

• Lifestyle factors

• Tissue characteristics

• Individual biological response

Higher-movement areas, including the lips, may demonstrate different persistence compared with less mobile facial regions.

Maintenance treatment may subsequently be considered following professional reassessment.

Storage & Handling

ELASTY® D Plus should be stored and handled according to the manufacturer's current Instructions for Use and the information supplied with the original product.

To maintain product integrity:

• Keep the product within its original packaging until required.

• Follow manufacturer-specified storage conditions.

• Protect from inappropriate environmental exposure.

• Inspect the syringe and outer packaging before use.

• Check the batch number and expiry date.

• Verify product authenticity and traceability.

• Maintain appropriate aseptic handling procedures.

• Do not use if sterile packaging is damaged.

• Do not use if the syringe appears compromised.

• Do not use after the stated expiry date.

Each syringe is intended for single use according to the manufacturer's Instructions for Use.

Important Information

ELASTY® D Plus with Lidocaine is intended strictly for use by appropriately qualified and trained medical or aesthetic professionals.

Professional knowledge of the following is essential:

• Facial anatomy

• Vascular anatomy

• Dermal filler techniques

• Appropriate treatment planes

• Patient selection

• Aseptic practice

• Lidocaine-containing injectable products

• Complication prevention

• Recognition of vascular compromise

• Emergency management

• Dermal filler complication management

Patient Assessment

Treatment should only proceed following:

• Full patient consultation

• Comprehensive medical history

• Detailed facial assessment

• Examination of the proposed treatment area

• Review of previous aesthetic treatments

• Assessment of contraindications

• Assessment of known allergies and hypersensitivities

• Consideration of Lidocaine-related contraindications

• Discussion of expected outcomes

• Explanation of potential adverse effects and complications

• Appropriate documented informed consent

Contraindications & Precautions

The supplied product information does not provide a complete manufacturer-defined contraindication list.

Treatment suitability should be carefully assessed where relevant factors include:

• Active infection or inflammation within the treatment area

• Known hypersensitivity to product components

• Known Lidocaine hypersensitivity

• Pregnancy or breastfeeding

• Uncontrolled medical conditions

• Other contraindications identified within the manufacturer's current Instructions for Use

This list is not exhaustive.

Potential Treatment Reactions

Temporary effects associated with injectable HA filler treatment may include:

• Redness

• Swelling

• Bruising

• Tenderness

• Discomfort

• Localised firmness

• Temporary contour irregularity

The precise product-specific adverse-event profile should be confirmed from the manufacturer's current Instructions for Use.

Serious Dermal Filler Complications

Injectable dermal filler procedures can result in serious complications, including infection, inflammatory reactions and vascular complications.

Inadvertent intravascular administration can result in vascular occlusion and serious tissue injury. Depending upon the anatomical area involved, complications may include tissue necrosis, visual impairment or blindness.

Practitioners must therefore have appropriate knowledge of facial vascular anatomy and be competent in recognising and managing filler-related complications.

Patients should receive appropriate written aftercare information and clear instructions regarding symptoms requiring urgent medical assessment.

Always consult the manufacturer's current Instructions for Use for complete information regarding indications, contraindications, warnings, precautions, administration and potential adverse events.

For appropriately qualified professional use only.